C
Patient Opportunity Trust Class FI LMOFX
NASDAQ
Recommendation
NAV
Total Assets
Dividend Yield
Turnover Ratio
Expense Ratio
Weiss Ratings LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Fair
Reward Grade C
Risk Index Weak
Risk Grade D+
Company Info LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Provider Patient Capital Management
Manager/Tenure (Years) Samantha McLemore (18), Christina Malbon (3)
Website http://www.patientcapitalmanagement.com
Fund Information LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Fund Name Patient Opportunity Trust Class FI
Category Mid-Cap Value
Sub-Category US Equity Mid Cap
Prospectus Objective Growth
Inception Date Feb 13, 2004
Open/Closed To New Investors Open
Minimum Initial Investment 0.00
Minimum Subsequent Investment --
Front End Fee --
Back End Fee --
Dividends and Shares LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Yield 0.00%
Dividend LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Yield (Forward) 1.09%
Asset Allocation LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash -0.81%
Stock 97.53%
U.S. Stock 91.44%
Non-U.S. Stock 6.09%
Bond 0.00%
U.S. Bond 0.00%
Non-U.S. Bond 0.00%
Preferred 0.56%
Convertible 0.00%
Other Net 2.72%
Price History LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -0.70%
30-Day Total Return -4.22%
60-Day Total Return -6.81%
90-Day Total Return -6.74%
Year to Date Total Return 10.10%
1-Year Total Return 17.72%
2-Year Total Return 46.38%
3-Year Total Return 112.61%
5-Year Total Return 39.98%
Price LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Closing Price --
1-Month Low Price --
1-Month High Price --
52-Week Low Price --
52-Week Low Price (Date) --
52-Week High Price --
52-Week High Price (Date) --
NAV LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Nav $55.26
1-Month Low NAV $55.04
1-Month High NAV $57.68
52-Week Low NAV $44.94
52-Week Low NAV (Date) Mar 30, 2026
52-Week High NAV $59.69
52-Week High Price (Date) Sep 03, 2026
Beta / Standard Deviation LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.38
Standard Deviation 19.60
Balance Sheet LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Total Assets 2.01B
Operating Ratios LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Expense Ratio 1.74%
Turnover Ratio 27.00%
Performance LMOFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Last Bull Market Total Return 46.91%
Last Bear Market Total Return -29.50%